Eli Lilly Missed Sales Expectations Again. Should Investors Be Worried?
In the first half of 2024, it seemed Eli Lilly (NYSE: LLY) could do no wrong. Is Eli Lilly a good stock to buy on the dip? On Jan. 14, CEO David Ricks told investors that 2024 sales would come in at ...
Jim Cramer on Eli Lilly and Company (LLY)’s Q4 2024 Performance: ‘Aren’t As Strong As Wall Street Was Hoping’
We recently compiled a list of the 9 Stocks on Jim Cramer’s Radar. In this article, we are going to take a look at where Eli ...
Tim's Sunday AM Forecast
Ahead of Donald Trump's inauguration on Monday, activist took to the San Francisco streets to rally against the incoming ...
Hosted on MSN2h
Nike Zoom LeBron NXXT Genisus “Viotech” sneakers: First look, design details, and everything we know so far
The Nike Lebron NXXT GEN Genisus “Viotech” sneakers are set to make their debut in the market. The latest model represents a ...
The McDowell News23h
Obesity won't be solely defined by BMI under new plan for diagnosis by global experts
New recommendations on how to define obesity would reduce the emphasis on body mass index and take into account health ...